ELP5

Across TCGA pan-cancer cohorts, ELP5 mass-spec protein differs between tumor and matched normal tissue in 5 of 18 cancer types tested, making tumor–normal expression one of ELP5’s most consistent transcriptional readouts.

The strongest signal is observed in pancreatic ductal adenocarcinoma (PDAC), where ELP5 mass-spec protein is repressed in tumor relative to normal tissue. In most cancer types ELP5 is over-expressed in tumor, although a few such as PDAC and CCRCC show the opposite, repressed pattern.

PDAC, CCRCC, and LUAD are the cancer types where ELP5 tumor–normal differential expression is most reproducible.

mass-spec protein tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in ELP5 mass-spec protein (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
PDAC	All	III,IV	−0.706	<.001	10	view →
CCRCC	Male	All	−0.206	<.001	9	view →
LUAD	Female	II,III,IV	−0.282	<.001	7	view →
LSCC	All	All	−0.144	<.001	7	view →
HNSC	Male	II,III,IV	−0.112	.007	5	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 5 strongest of 5 lineages.

ELP5–PDAC

Open the PDAC breakdown →